{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:46:12Z","timestamp":1751953572179},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12185-014-1584-0","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T07:34:15Z","timestamp":1398411255000},"page":"794-797","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21"],"prefix":"10.1007","volume":"99","author":[{"given":"Francesco","family":"Corazza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Astolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Libri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Franzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Serravalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosina","family":"Alessandroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraia","family":"Melchionda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,26]]},"reference":[{"key":"1584_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.siny.2012.02.010","volume":"17","author":"A Roy","year":"2012","unstructured":"Roy A, Roberts I, Vyas P. Biology and management of transient abnormal myelopoiesis (TAM) in children with down syndrome. Semin Fetal Neonatal Med. 2012;17:196\u2013201.","journal-title":"Semin Fetal Neonatal Med"},{"key":"1584_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bjh.12041","volume":"159","author":"AS Gamis","year":"2012","unstructured":"Gamis AS, Smith FO. Transient myeloproliferative disorder in children with down syndrome: clarity to this enigmatic disorder. Br J Haematol. 2012;159:277\u201387.","journal-title":"Br J Haematol"},{"key":"1584_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/MPH.0b013e31818a953e","volume":"30","author":"N Apollonsky","year":"2008","unstructured":"Apollonsky N, Shende A, Ouansafi I, Brody J, Atlas M, Aygun B. Transient myeloproliferative disorder in neonates with and without down syndrome: a tale of 2 syndromes. J Pediatr Hematol Oncol. 2008;30:860\u20134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1584_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/MPH.0b013e318249597f","volume":"34","author":"K Kawase","year":"2012","unstructured":"Kawase K, Azuma E, Ohshita H, Tanaka T, Hanada Y, Sasaki T, et al. Risk factors for early death in transient myeloproliferative disorder without phenotypic features of down syndrome: a case report and literature review. J Pediatr Hematol Oncol. 2012;34:475\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1584_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12185-010-0646-1","volume":"92","author":"K Yanase","year":"2010","unstructured":"Yanase K, Kato K, Katayama N, Mouri Y, Kobayashi C, Shiono J, et al. Transient abnormal myelopoiesis in a cytogenetically normal neonate. Int J Hematol. 2010;92:527\u201330.","journal-title":"Int J Hematol"},{"key":"1584_CR6","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","volume":"110","author":"SR Pine","year":"2007","unstructured":"Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with down syndrome. Blood. 2007;110:2128\u201331.","journal-title":"Blood"},{"key":"1584_CR7","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","volume":"103","author":"M Ahmed","year":"2004","unstructured":"Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O\u2019Marcaigh A, et al. Natural history of GATA1 mutations in down syndrome. Blood. 2004;103:2480\u20139.","journal-title":"Blood"},{"key":"1584_CR8","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","volume":"111","author":"JH Klusmann","year":"2008","unstructured":"Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, et al. Treatment and prognostic impact of transient leukemia in neonates with down syndrome. Blood. 2008;111:2991\u20138.","journal-title":"Blood"},{"key":"1584_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of down syndrome. Nat Genet. 2002;32:148\u201352.","journal-title":"Nat Genet"},{"key":"1584_CR10","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","volume":"118","author":"AS Gamis","year":"2011","unstructured":"Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in down syndrome neonates: a report from the children\u2019s oncology group study A2971. Blood. 2011;118:6752\u20139.","journal-title":"Blood"},{"key":"1584_CR11","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1111\/cas.12007","volume":"103","author":"R Shimizu","year":"2012","unstructured":"Shimizu R, Yamamoto M. Contribution of GATA1 dysfunction to multi-step leukemogenesis. Cancer Sci. 2012;103:2039\u201344.","journal-title":"Cancer Sci"},{"issue":"4377\u201387","key":"1584_CR12","first-page":"12","volume":"121","author":"S Saida","year":"2013","unstructured":"Saida S, Watanabe KI, Sato-Otsubo A, Terui K, Yoshida K, Okuno Y, et al. Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in down syndrome. Blood. 2013;121(4377\u201387):12.","journal-title":"Blood"},{"key":"1584_CR13","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","volume":"113","author":"S Malinge","year":"2009","unstructured":"Malinge S, Izraeli S, Crispino JD. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in down syndrome. Blood. 2009;113:2619\u201328.","journal-title":"Blood"},{"key":"1584_CR14","unstructured":"ISCN 2009. An international system for human cytogenetic nomenclature. In: Shaffer LG, Slovak ML, Campbell LJ editors, Basel: S Karger; 2009."},{"key":"1584_CR15","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","volume":"107","author":"GV Massey","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, et al. Children\u2019s oncology group. A prospective study of the natural history of transient leukemia (TL) in neonates with down syndrome: children\u2019s oncology group study POG-9481. Blood. 2006;107:4606\u201313.","journal-title":"Blood"},{"key":"1584_CR16","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1182\/blood-2005-03-1071","volume":"106","author":"J Groet","year":"2005","unstructured":"Groet J, Mulligan C, Spinelli M, Serra A, McElwaine S, Cotter FE, et al. Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with down syndrome. Blood. 2005;106:1887\u20138.","journal-title":"Blood"},{"key":"1584_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/01.mph.0000212997.02554.f6","volume":"28","author":"G Xu","year":"2006","unstructured":"Xu G, Kato K, Toki T, Takahashi Y, Terui K, Ito E. Development of acute megakaryoblastic leukemia from a minor clone in a down syndrome patient with clinically overt transient myeloproliferative disorder. J Pediatr Hematol Oncol. 2006;28:696\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1584_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF03006929","volume":"86","author":"H Kanegane","year":"2007","unstructured":"Kanegane H, Watanabe S, Nomura K, Xu G, Ito E, Miyawaki T. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with down syndrome. Int J Hematol. 2007;86:250\u20132.","journal-title":"Int J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-014-1584-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1584-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:12:09Z","timestamp":1659096729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-014-1584-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,26]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1584-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,26]]},"assertion":[{"value":"20 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}